Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7869802 | 1.00 | CCR5 (0.54) | CCR5 | |
| SCHEMBL7868351 | 0.91 | CCR5 (0.56) | CCR5 | |
| SCHEMBL7868353 | 0.91 | CCR5 (0.56) | CCR5 | |
| SCHEMBL7867920 | 0.90 | CCR5 (0.54) | CCR5 | |
| SCHEMBL7863093 | 0.90 | CCR5 (0.54) | CCR5 | |
| SCHEMBL7868175 | 0.89 | CCR5 (0.52) | CCR5 | |
| SCHEMBL7868170 | 0.89 | CCR5 (0.52) | CCR5 | |
| SCHEMBL7863006 | 0.88 | CCR5 (0.61) | CCR5 | |
| SCHEMBL7871375 | 0.88 | CCR5 (0.56) | CCR5 | |
| SCHEMBL7871373 | 0.88 | CCR5 (0.56) | CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6303593-B1 | FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS | MERCK & CO., INC. | 2001-10-16 | — | — | US | claimed |
| US-6303593-B1 | FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS | MERCK & CO., INC. | 2001-10-16 | — | — | US | disclosed |